Lotilaner

Lotilaner (CAS 1398609-39-6) is a systemic isoxazoline ectoparasiticide developed for veterinary use, primarily in dogs and cats. It acts by inhibiting GABA- and glutamate-gated chloride channels, leading to rapid paralysis and death of fleas and ticks. This compound is characterized by its high potency and prolonged duration of action, making it a preferred choice in oral formulations for ectoparasite control.

We supply Lotilaner as a white to off-white powder with a purity of ≥98% (HPLC), suitable for pharmaceutical formulation and veterinary product development. Each batch is accompanied by a COA, MSDS, and TDS, ensuring traceability and compliance with regulatory standards.

Synonyme: Lotilaner, 4-[(5RS)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-N-[(4-methoxyphenyl)methyl]-2-methylbenzamide

Anwendungen

• Veterinary oral solutions for flea and tick control in dogs and cats
• Combination products with other antiparasitic agents
• R&D for novel ectoparasiticide formulations

Qualität und Dokumentation

Every batch is tested for assay (HPLC ≥98%), loss on drying (≤0.5%), and heavy metals (≤10 ppm). Full COA, MSDS, and TDS are available on request. Stability data can be provided to support your qualification and registration processes.

Verpackung und Beschaffung

Standardverpackungen: 1 kg, 5 kg, 25 kg; Großmengen und Sonderverpackungen sind ebenfalls erhältlich. Lagerware wird innerhalb von 3–5 Tagen versandt; Mindestbestellmenge ab 1 kg. Für Preisauskünfte und Muster wenden Sie sich bitte an unser Vertriebsteam.

Angebotsanfrage

• Unsere Adresse: 280 Main Street, Xi’an, Shaanxi, China
• LyvBio GmbH. — E-Mail: info@lyvbio.com